AGE1

THE accelerator for breakthrough longevity companies

3 Months | Up to $500k in funding | Unparalleled Expertise

 
 
 
Screen+Shot+2019-09-09+at+8.36.31+AM.jpg
 
0.jpg

About AGE1

AGE1 is a San Francisco based 3-month accelerator for scientists and technologists working to combat age-related disease.
Learn more

 

AGE1 Investors  

 
longevity-1.png
felicis.png
foundersfund.png
 

AGE1 Mentors & Advisors

Screen Shot 2019-09-09 at 8.42.27 AM.png

Laura Deming
Partner, Longevity Fund

Marc Andreessen
Partner, A16z

Elad Gil
Co-Founder, Color Genomics

Our Impact

 

10

COmpanies

Previous AGE1 companies include Spring Discovery, Fauna Bio, and Deciduous Therapeutics. See featured AGE1 companies .

$30M

Follow on Funding Raised

AGE1 companies have gone on to raise upwards of $30M from VCs including First Round Capital, General Catalyst, and CRV.


"Spring Discovery would not exist without AGE1.”

Ben Kamens, Founder & CEO at Spring Discovery